Invesco Ltd. - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 133 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$645,572
-18.6%
195,037
-0.6%
0.00%
Q1 2024$792,906
+17.3%
196,264
-11.4%
0.00%
Q4 2023$675,773
+6.2%
221,565
+4.5%
0.00%
Q3 2023$636,333
-19.2%
212,111
+0.8%
0.00%
Q2 2023$787,383
+8.4%
210,530
-2.9%
0.00%
Q1 2023$726,193
+2.1%
216,774
+46.5%
0.00%
Q4 2022$711,538
+7.2%
147,929
+26.8%
0.00%
Q3 2022$664,000
-22.8%
116,640
-3.7%
0.00%
Q2 2022$860,000
+13.5%
121,132
+15.3%
0.00%
Q1 2022$758,000
+155.2%
105,018
+215.4%
0.00%
Q4 2021$297,000
-97.3%
33,293
-89.5%
0.00%
-100.0%
Q3 2021$11,134,000
+2279.1%
317,579
+1356.9%
0.00%
Q2 2021$468,000
-11.2%
21,798
+155.2%
0.00%
Q1 2021$527,0008,5420.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 5,462,079$16,659,34112.62%
TANG CAPITAL MANAGEMENT LLC 4,076,741$12,434,0601.15%
Stonepine Capital Management, LLC 839,514$2,560,5181.11%
Bain Capital Life Sciences Investors, LLC 2,485,638$7,581,1960.73%
CM Management, LLC 270,000$823,5000.66%
EcoR1 Capital, LLC 6,995,861$21,337,3760.55%
Acuitas Investments, LLC 171,098$615,3730.32%
Newtyn Management, LLC 508,474$1,550,8460.30%
Diametric Capital, LP 161,524$492,6480.30%
Auour Investments LLC 177,000$670,8300.26%
View complete list of ATEA PHARMACEUTICALS INC shareholders